Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis

OBJECTIVE: To describe the pharmacodynamic monitoring of (immuno)proteasome inhibition following treatment with bortezomib in a therapy-refractory systemic lupus erythematosus (SLE) patient with life-threatening myocarditis and lupus nephritis. PATIENT AND METHODS: Inhibition of catalytic activities...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot, Karina A, Tsang a Sjoe, Michel, Niewerth, Denise, Cloos, Jacqueline, Blank, Jonathan L, Niessen, Hans W M, Zweegman, Sonja, Voskuyl, Alexandre E, Jansen, Gerrit, van der Heijden, Joost W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691954/
https://www.ncbi.nlm.nih.gov/pubmed/26719810
http://dx.doi.org/10.1136/lupus-2015-000121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691954/
https://www.ncbi.nlm.nih.gov/pubmed/26719810
http://dx.doi.org/10.1136/lupus-2015-000121

Ejemplares similares